Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Total Current Liabilities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Total Current Liabilities for 6 consecutive years, with $2.5 million as the latest value for Q3 2018.

  • Quarterly Total Current Liabilities changed 0.48% to $2.5 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2018, changed 0.48% year-over-year, with the annual reading at $2.0 million for FY2017, 44.38% down from the prior year.
  • Total Current Liabilities hit $2.5 million in Q3 2018 for Armata Pharmaceuticals, up from $2.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.7 million in Q2 2017 to a low of $1.0 million in Q1 2014.
  • Historically, Total Current Liabilities has averaged $2.4 million across 5 years, with a median of $2.4 million in 2015.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 106.82% in 2015 and later crashed 44.79% in 2018.
  • Year by year, Total Current Liabilities stood at $1.9 million in 2014, then increased by 27.68% to $2.4 million in 2015, then soared by 48.34% to $3.5 million in 2016, then plummeted by 44.38% to $2.0 million in 2017, then grew by 25.25% to $2.5 million in 2018.
  • Business Quant data shows Total Current Liabilities for ARMP at $2.5 million in Q3 2018, $2.0 million in Q2 2018, and $1.8 million in Q1 2018.